Skip to main content

Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence-Based Guidelines in Clinical Practice

Abstract

Background

Implementation of evidence-based standards is problematic. Level 1 evidence, largely predicated on the German Rectal Cancer Study, supports neoadjuvant treatment for patients with stage II/III rectal cancer. The purpose of this study was to determine to what extent this evidence has affected clinical practice.

Methods

Stage II/III rectal cancer patients undergoing surgery from 1998 to 2007 were identified in the SEER tumor registry. Variables were analyzed with SPSS software. Trends were evaluated with regression models. Survivals were compared with the log-rank test.

Results

A total of 22,136 patients were identified and 15,021 (67.8 %) were treated with adjuvant radiotherapy. A large percentage were >60 years old (64.4 %), white (83.0 %), male (58.8 %), at stage III (55.1 %), and treated with neoadjuvant radiotherapy (35.5 %). A significant increase in the use of neoadjuvant radiotherapy occurred: from 17 % in 1998 to 51 % in 2007 (p < 0.001). Scatter-plot best-fit lines for neoadjuvant and adjuvant radiotherapy intersected at approximately year 2002. Significant increases in preoperative radiotherapy were observed for all races and cancer stages (p < 0.001). On unadjusted analysis, race (p = 0.018), sex (p < 0.001), year of diagnosis (p < 0.001), age (p < 0.001), and stage (p < 0.001) were associated with increased likelihood of neoadjuvant radiotherapy. On logistic regression analysis, male sex [odds ratio (OR) 1.14, p < 0.001), year (OR 1.223, p < 0.001), and stage II (OR 1.39, p < 0.001) were predictors of neoadjuvant therapy.

Conclusions

When adjuvant radiotherapy was utilized, there was rapid adoption of a neoadjuvant approach. This trend predated publication of prospective randomized data.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Haynes B, Haines A (1998) Barriers and bridges to evidence based clinical practice. BMJ 317:273–276

    PubMed  Article  CAS  Google Scholar 

  2. Heffner JE (2000) The overarching challenge. Chest 118:1S–3S

    PubMed  Article  CAS  Google Scholar 

  3. Hewitt M, Simone JV (eds) (1999) Ensuring quality cancer care. National Academy Press, Washington, DC

    Google Scholar 

  4. Elferink MA, Krijnen P, Wouters MW et al (2010) Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in The Netherlands. Eur J Surg Oncol 36(Suppl 1):74–82

    Article  Google Scholar 

  5. Jullumstro E, Wibe A, Lydersen S et al (2012) Violation of treatment guidelines: hazard for rectal cancer patients. Int J Colorectal Dis 27:103–109

    PubMed  Article  Google Scholar 

  6. Anonymous (1990) Adjuvant therapy for patients with colon and rectal cancer: National Institutes of Health. Conn Med 54:573–581

    Google Scholar 

  7. Hay JM, Msika S (2000) Radiotherapy and chemotherapy in the treatment of cancer of the rectum. J Chir (Paris) 137:13–15

    CAS  Google Scholar 

  8. Kuo I, Wong JH, Roy-Chowdhury S et al (2010) The use of pelvic radiation in stage II rectal cancer: a population-based analysis. Am Surg 76:1092–1095

    PubMed  Google Scholar 

  9. Roos M, Wong JH, Roy-Chowdhury S et al (2010) The impact of multidisciplinary therapy in node-positive rectal cancer. Am Surg 76:1163–1166

    PubMed  Google Scholar 

  10. Fitzgerald TL, Brinkley J, Zervos EE (2011) Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins. J Am Coll Surg 213:589–595

    PubMed  Article  Google Scholar 

  11. Madoff RD (2004) Chemoradiotherapy for rectal cancer: when, why, and how? N Engl J Med 351:1790–1792

    PubMed  Article  CAS  Google Scholar 

  12. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    PubMed  Article  CAS  Google Scholar 

  13. Valentini V, Coco C, Gambacorta MA et al (2010) Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). Acta Chir Iugosl 57:9–16

    PubMed  Article  CAS  Google Scholar 

  14. Engstrom PF, Arnoletti JP, Benson AB 3rd et al (2009) NCCN clinical practice guidelines in oncology: rectal cancer. J Natl Compr Canc Netw 7:838–881

    PubMed  Google Scholar 

  15. Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging handbook. Springer, New York

    Google Scholar 

  16. Shiffman RN, Dixon J, Brandt C et al (2005) The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak 5:23

    PubMed  Article  Google Scholar 

  17. Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294:2703–2711

    PubMed  Article  CAS  Google Scholar 

  18. Sheldon TA, Guyatt GH, Haines A (1998) Getting research findings into practice: when to act on the evidence. BMJ 317:139–142

    PubMed  Article  CAS  Google Scholar 

  19. Heffner JE (2000) The overarching challenge. Chest 118:1S–3S

    PubMed  Article  CAS  Google Scholar 

  20. Anonymous (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish rectal cancer trial. N Engl J Med 336:980–987

    Article  Google Scholar 

  21. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646

    PubMed  Article  CAS  Google Scholar 

  22. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123

    PubMed  Article  CAS  Google Scholar 

  23. Valentini V, Glimelius B (2010) Rectal cancer radiotherapy: towards European consensus. Acta Oncol 49:1206–1216

    PubMed  Article  Google Scholar 

  24. Glimelius B, Pahlman L, Cervantes (2010) A rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v82–v86

    PubMed  Article  Google Scholar 

  25. Wong RK, Berry S, Spithoff K et al (2010) Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) 22:265–271

    Article  CAS  Google Scholar 

  26. Eldin NS, Yasui Y, Scarfe A et al (2012) Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol (R Coll Radiol) 24:e9–e17

    Article  Google Scholar 

  27. Srinivasaiah N, Joseph B, Mackey P et al (2008) How do we manage early rectal cancer? A national questionnaire survey among members of the ACPGBI after the preliminary results of the MRC CR07/NCIC CO16 randomized trial. Colorectal Dis 10:357–362

    PubMed  Article  CAS  Google Scholar 

  28. Ooi K, Frizelle F, Ong E et al (2011) Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: a bi-national survey. Colorectal Dis 14:814–820

    Article  Google Scholar 

  29. Jullumstro E, Wibe A, Lydersen S et al (2012) Violation of treatment guidelines: hazard for rectal cancer patients. Int J Colorectal Dis 27:103–109

    PubMed  Article  Google Scholar 

  30. Eldin NS, Yasui Y, Scarfe A et al (2012) Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol (R Coll Radiol) 24:e9–e17

    Article  Google Scholar 

  31. Manchon-Walsh P, Borras JM, Espinas JA et al (2011) Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol 37:325–333

    PubMed  Article  CAS  Google Scholar 

  32. Boyle E, Timmons A, Al-Akash M et al (2011) The management of rectal cancer in Ireland in 2007—room for improvement? Surgeon 9:179–186

    PubMed  Article  CAS  Google Scholar 

  33. Jobsen JJ, Aarts MJ, Siesling S et al (2012) Use of primary radiotherapy for rectal cancer in The Netherlands between 1997 and 2008: a population-based study. Clin Oncol (R Coll Radiol) 24:e1–e8

    Article  CAS  Google Scholar 

  34. Mak RH, McCarthy EP, Das P et al (2011) Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a surveillance, epidemiology, and end results patterns-of-care study. Int J Radiat Oncol Biol Phys 80:978–984

    PubMed  Article  Google Scholar 

  35. Brown G (2008) Staging rectal cancer: endoscopicand pelvic MRI. Cancer Imaging 8(Spec No A):S43–S45

    PubMed  Article  Google Scholar 

  36. Bellows CF, Jaffe B, Bacigalupo L et al (2011) Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol 3:92–104

    PubMed  Article  Google Scholar 

  37. Zuckerman IH, Rapp T, Onukwugha E et al (2009) Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer. J Am Geriatr Soc 57:1403–1410

    PubMed  Article  Google Scholar 

  38. Fata F, Mirza A, Craig G et al (2002) Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 94:1931–1938

    PubMed  Article  CAS  Google Scholar 

  39. Sundararajan V, Mitra N, Jacobson JS et al (2002) Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 136:349–357

    PubMed  CAS  Google Scholar 

  40. Margalit DN, Mamon HJ, Ancukiewicz M et al (2011) Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys 81:e735–e741

    PubMed  Article  Google Scholar 

  41. Quipourt V, Jooste V, Cottet V et al (2011) Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study. J Am Geriatr Soc 59:694–698

    PubMed  Article  Google Scholar 

  42. Kurtz JE, Heitz D, Serra S et al (2010) Adjuvant chemotherapy in elderly patients with colorectal cancer: a retrospective analysis of the implementation of tumor board recommendations in a single institution. Crit Rev Oncol Hematol 74:211–217

    PubMed  Article  Google Scholar 

  43. Wo JY, Mamon HJ, Ryan DP et al (2011) T3N0 rectal cancer: radiation for all? Semin Radiat Oncol 21:212–219

    PubMed  Article  Google Scholar 

  44. Birgisson H, Pahlman L, Gunnarsson U et al (2007) Late adverse effects of radiation therapy for rectal cancer: a systematic overview. Acta Oncol 46:504–516

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Timothy L. Fitzgerald.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fitzgerald, T.L., Biswas, T., O’Brien, K. et al. Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence-Based Guidelines in Clinical Practice. World J Surg 37, 639–645 (2013). https://doi.org/10.1007/s00268-012-1862-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-012-1862-z

Keywords

  • Rectal Cancer
  • Adjuvant Radiotherapy
  • Total Mesorectal Excision
  • Preoperative Radiotherapy
  • Rectal Cancer Patient